We are live on ! Find out more
CALC icon

CalciMedica
CALC

20 hedge funds and large institutions have $14.8M invested in CalciMedica in 2024 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

892% more capital invested

Capital invested by funds: $1.49M → $14.8M (+$13.3M)

800% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 1

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

67% more funds holding

Funds holding: 12 → 20 (+8)

23.93% more ownership

Funds ownership: 9.12% → 33.05% (+24%)

Holders
20
Holders Change
+8
Holders Change %
+66.67%
% of All Funds
0.29%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
9
Increased
6
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
DM
Deerfield Management
New York
+$4.57M
2
SCM
Soleus Capital Management
Connecticut
+$3.58M
3
SCM
Stonepine Capital Management
Oregon
+$2.39M
4
ACM
Aisling Capital Management
New York
+$2.38M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$343K

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$3.91K
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$4.16M +$4.57M +1,000,000 New
SCM
2
Soleus Capital Management
Connecticut
$3.26M +$3.58M +783,904 New
SCM
3
Stonepine Capital Management
Oregon
$2.17M +$2.39M +522,602 New
ACM
4
Aisling Capital Management
New York
$2.17M +$2.38M +521,114 New
O
5
OrbiMed
New York
$1.24M – – –
BCM
6
BML Capital Management
Indiana
$667K +$68.5K +15,000 +10%
Alyeska Investment Group
7
Alyeska Investment Group
Illinois
$312K +$343K +75,082 New
Millennium Management
8
Millennium Management
New York
$275K +$302K +66,134 New
MPM
9
Meritage Portfolio Management
Kansas
$191K – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$186K +$143K +31,332 +235%
Vanguard Group
11
Vanguard Group
Pennsylvania
$55.6K +$61K +13,359 New
First Manhattan
12
First Manhattan
New York
$55K – – –
TRCT
13
Tower Research Capital (TRC)
New York
$10.9K +$3.49K +764 +54%
Qube Research & Technologies (QRT)
14
Qube Research & Technologies (QRT)
United Kingdom
$5.11K +$5.61K +1,228 +122,800%
Morgan Stanley
15
Morgan Stanley
New York
$3.56K -$3.91K -856 -50%
ACM
16
ADAR1 Capital Management
Texas
$3.25K +$3.57K +781 New
Bank of America
17
Bank of America
North Carolina
$2.11K – – –
Wells Fargo
18
Wells Fargo
California
$229 +$178 +39 +244%
UBS Group
19
UBS Group
Switzerland
$66 +$9 +2 +14%
JP Morgan Chase
20
JP Morgan Chase
New York
$58 +$64 +14 New

CALC Hedge Fund Activity: Q1 2024 in Review

20 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q1 2024, worth a combined $14.8M — up 892% from $1.49M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new CALC positions and 1 closed out — a net gain of 8 holders — while 6 added to existing stakes and 1 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $4.57M. The largest seller was Morgan Stanley, cutting an estimated $3.91K.

  • 20 institutional investors held CalciMedica (CALC) as of Q1 2024, up from 12 in Q4 2023.
  • Funds reported $14.8M of CalciMedica stock for Q1 2024, up 892% quarter-over-quarter.
  • 9 funds opened new CalciMedica positions in Q1 2024 and 1 closed out, a net change of +8 holders.
  • The largest CalciMedica buyer in Q1 2024 was Deerfield Management, an estimated $4.57M added.
  • The largest CalciMedica seller in Q1 2024 was Morgan Stanley, an estimated $3.91K sold.

Based on aggregated 13F filings for Q1 2024.